Fructose-fused γ-butyrolactones and lactams, synthesis and biological evaluation as GABA receptor ligands

Carbohydrate Research

Volumn 343, Issue 10-11, 2008, Pages 1840-1848

  Araújo, Ana C ^a   Nicotra, Francesco ^b   Costa, Barbara ^b   Giagnoni, Gabriella ^b   Cipolla, Laura ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

C Glycosides; Fructose; GABA receptors; Butyrolactams; Butyrolactones

Indexed keywords

CARBOHYDRATES; LIGANDS; SYNTHESIS (CHEMICAL);

C-GLYCOSIDES; GABA RECEPTORS; Γ-BUTYROLACTAMS; Γ-BUTYROLACTONES;

FRUCTOSE;

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3,6 ANHYDRO 2 DEOXY 3 C (AMINOMETHYL) MANNO HEPTONIC ACID LACTAM; 3,6 ANHYDRO 2 DEOXY 3 C (HYDROXYMETHYL) MANNO HEPTONIC ACID LACTONE; 3,6 ANHYDRO 2 DEOXY 3 C [AMINOMETHYL(N TERT BUTOXYCARBONYL)] MANNO HEPTONIC ACID LACTAM; 3,6 ANHYDRO 4,5,7 TRI O BENZYL 2 DEOXY 3 C (AMINOMETHYL) MANNO HEPTONIC ACID LACTAM; 3,6 ANHYDRO 4,5,7 TRI O BENZYL 2 DEOXY 3 C (HYDROXYMETHYL) MANNO HEPTONIC ACID LACTONE; 3,6 ANHYDRO 4,5,7 TRI O BENZYL 2 DEOXY 3 C [AMINOMETHYL (N TERT BUTOXYCARBONYL)] MANNO HEPTONIC ACID LACTAM; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; C FRUCTOSIDE; CARBOHYDRATE DERIVATIVE; FRUCTOSE; GABAPENTIN; GABOXADOL; GALACTOSE; GAMMA BUTYROLACTAM DERIVATIVE; GAMMA BUTYROLACTONE DERIVATIVE; GLUCOSE; GLYCOSIDE; LACTAM DERIVATIVE; MUSCIMOL; PROGABIDE; VIGABATRIN;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL;

EID: 46549086539     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carres.2008.03.013     Document Type: Article

References (61)

1. Tanaka C., and Bowery N.G. GABA: Receptors, Transporters and Metabolism (1996), Birkhäuser, Basel
2. Rang H.P., Dale M.M., and Ritter J.M. Gamma-Aminobutyric Acid (GABA). Pharmacology. 4th ed. (1999), Churchill Livingstone, Edinburgh 478-480
3. Farrant M., and Nusser Z. Nat. Rev. Neurosci. 6 (2005) 215-229
4. Chebib M., and Johnston G.A.R. Clin. Exp. Pharmaol. Physiol. 26 (1999) 937-940
5. Atack J.R. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 213-232
6. Atack J.R. Expert Opin. Invest. Drugs 14 (2005) 601-618
7. Cryan J.F., and Kaupmann K. Trends Pharmacol. Sci. 26 (2004) 36-43
8. Nutt D.J., and Malizia A.L. Br. J. Psychiatry 179 (2001) 390-396
9. Sandford J.J., Argyropoulos S.V., and Nutt D.J. Pharmacol. Ther. 88 (2000) 197-212
10. Argyropoulos S.V., Sandford J.J., and Nutt D.J. Pharmacol. Ther. 88 (2000) 213-227
11. Kalueff A.V., and Nutt D.J. Anxiety Depress. 4 (1997) 100-110
12. For recent reviews on GABA receptor ligands and pharmacology see, for example:. Kalueff A.V. Neurochem. Int. 50 (2007) 61-68
13. Hog S., Greenwood J.R., Madsen K.B., Larsson O.M., Frolund B., Schousboe A., Krogsgaard-Larsen P., and Calusen R. Curr. Top. Med. Chem. 6 (2006) 1861-1882
14. Chebib M., and Johnston G.A.R. J. Med. Chem. 43 (2000) 1427-1447
15. Olsen R.W., Chang C.-S.S., Li G., Hanchar H.J., and Wallner M. Biochem. Pharmacol. 68 (2004) 1675-1684
16. Korpi E.R., Grunder G., and Luddens H. Prog. Neurobiol. 67 (2002) 113-159
17. Krogsgaard-Larsen P., Frølund B., Kristiansen U., Frydenvang K., and Ebert B. Eur. J. Pharm. Sci. 5 (1997) 355-384
18. Johnston G.A.R. Pharmacol. Ther. 69 (1996) 173-198
19. Bernard C., Cossart R., Hirsch J.C., Esclapez M., and Ben-Ari Y. Epilepsia 41 (2000) S90-S95
20. Wong C.G.T., Bottiglieri T., and Snead O.C. Ann. Neurol. 54 (2003) S3-S12
21. Lydiard R.B. J. Clin. Psychiatry 64 (2003) 21-27
22. Hosak L., and Libiger J. Eur. Psychiatry 17 (2002) 371-378
23. Levy L.M., Dalakas M.C., and Floeter M.K. Ann. Intern. Med. 131 (1999) 522-530
24. Cooper J.R., Bloom F.E., and Roth R.H. Amino Acid Transmitters. In: Cooper J.R., Bloom F.E., and Roth R.H. (Eds). The Biochemical Basis of Neuropharmacology. 6th ed. (1991), Oxford University Press, Oxford, UK 133-189
25. Vemulapalli S., and Barletta M. Arch. Int. Pharmacodyn. Ther. 267 (1984) 46-58
26. Nurnberger J.I., Berrettini W.H., Simmons-Alling S., Guroff J.I., and Gershon E.S. Psychiatry Res. 19 (1986) 113-117
27. Bryans J.S., and Wustrow D.J. Med. Res. Rev. 19 (1999) 149-177
28. Hill M.W., de la Cruz M.A.M., Covey D.F., and Rothman S.M. Epilepsy Res. 37 (1999) 121-131
29. Hill M.W., Reddy P.A., Covey D.F., and Rothman S.M. J. Neurosci. 18 (1998) 5103-5111
30. Williams K.L., Tucker J.B., White G., Weiss D.S., Ferrendelli J.A., Covey D.F., Krause J.E., and Rothman S.M. Mol. Pharmacol. 52 (1997) 114-119
31. Maksay G., Molnár P., and Gruber L. Eur. J. Pharmacol. 288 (1994) 61-68
32. Kapferer T., and Bruckner R. Eur. J. Org. Chem. (2006) 2119-2133 and references cited therein
33. Ghosh M. Tetrahedron 63 (2007) 11710-11715
34. Takano E. Curr. Opin. Microbiol. 9 (2006) 287-294
35. Kar A., Gogoi S., and Argade N.P. Tetrahedron 61 (2005) 5297-5302
36. Konaklieva M.I., and Plotkin B.J. Mini Rev. Med. Chem. 5 (2005) 73-95
37. Ghoshala N., and Mukherjeeb P.K. Bioorg. Med. Chem. Lett. 14 (2004) 103-109
38. Gonzales E.B., Bell-Horner C.L., de la Cruz M.A.M., Ferrendelli J.A., Covey D.F., and Dillon G.H. J. Pharmacol. Exp. Ther. 309 (2003) 677-683
39. Razet R., Thomet U., Furtmuèller R., Jursky F., Sigel E., Sieghart W., and Dodd R.H. Bioorg. Med. Chem. Lett. 10 (2000) 2579-2583
40. Canney D.J., Lu H.-F., McKeon A.C., Yoon K.-W., Xu K., Holland K.D., Rothmand S.M., Ferrendelli J.A., and Covey D.F. Bioorg. Med. Chem. 6 (1998) 43-55
41. Holland K.D., Mathews G.C., Bolos-Sy A.M., Tucker J.B., Reddy P.A., Covey D.F., Ferrendelli J.A., and Rothman S.M. Mol. Pharmacol. 47 (1995) 1217-1223
42. Reddy P.A., Hsiang B.C., Latifi T.N., Hill M.W., Woodward K.E., Rothman S.M., Ferrendelli J.A., and Covey D.F. J. Med. Chem. 39 (1996) 1898-1906
43. Reddy P.A., Woodward K.E., McIlheran S.M., Hsiang B.C., Latifi T.N., Hill M.W., Rothman S.M., Ferrendelli J.A., and Covey D.F. J. Med. Chem. 40 (1997) 44-49
44. Peterson E.M., Xu K., Holland K.D., McKeon A.C., Rothman S.M., Ferrendelli J.A., and Covey D.F. J. Med. Chem. 37 (1994) 275-286
45. Rekatas G.V., Tani E.K., Demopoulos V.J., and Kourounakis P.N. Drug Dev. Res. 51 (2000) 143-148
46. Hill M.W., Reddy P.A., Covey D.F., and Rothman S.M. J. Pharmacol. Exp. Ther. 285 (1998) 1303-1309
47. Sasaki H., Mori Y., Nakamura J., and Shibasaki J. J. Med. Chem. 34 (1991) 628-633
48. Jehle T., Feuerstein T.J., and Lagreze W.A. Ophthalmologe 98 (2001) 237-241
49. Wall G.M., and Baker J.K. J. Med. Chem. 32 (1989) 1340-1348
50. Schweizer F., Otter A., and Hindsgaul O. Synlett (2001) 1743-1746
51. Schweizer F., and Hindsgaul O. Carbohydr. Res. 341 (2006) 1730-1736
52. Hanessian S. In: Baldwin J.E. (Ed). Total Synthesis of Natural Products: The 'Chiron' Approach (1983), Pergamon, Oxford
53. Hollingsworth R.I., and Wang G. Chem. Rev. 100 (2000) 4267-4282
54. Banks W.A., and Kastin A.J. Brain Res. Bull. 15 (1985) 287-292
55. Rapoport S.I., Ohno K., and Pettigrew K.D. Brain Res. 172 (1979) 354-359
56. Cipolla L., Forni E., Jimenéz-Barbero J., and Nicotra F. Chem. Eur. J. 8 (2000) 3976-3983
57. Cipolla L., Redaelli C., and Nicotra F. Lett. Drug Design Discov. 4 (2005) 291-293
58. Pappo R., Allen D.S., Lemieux R.U., and Johnson W.S. J. Org. Chem. 21 (1956) 478-479
59. Fleet G.W.J., and Son J.C. Tetrahedron 44 (1988) 2637-2647
60. Lee K., Zhang M., Liu H., Yang D., and Burke Jr. T.R. J. Med. Chem. 46 (2003) 2621-2630
61. Frosini M., Sesti C., Dragoni S., Valoti M., Palmi M., Dixon H.B.F., Machetti F., and Sgaragli G. Br. J. Pharmacol. 138 (2003) 1163-1171